Mays Ray L, the Executive Vice President and Chief Operating Officer of Dawson Geophysical Company, has reported a stock transaction involving the surrender of shares. This action, filed on October 29, 2026, is significant as it reflects the ongoing management of executive compensation and stock ownership.
Background
Dawson Geophysical Company, identified under the Central Index Key (CIK) 0000799165, operates within the oil and gas field exploration services sector. The company is incorporated in Texas and has its business address in Midland, Texas. The latest filing is part of a series of disclosures made by Mays Ray L, with previous filings dating back to as early as 2011.
What the Filing Says
The recent filing indicates that Mays Ray L surrendered 8,116 shares of Dawson Geophysical common stock on October 27, 2026. This transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock under the company’s incentive plan. The filing notes, "Represents the surrender of shares of Common Stock to satisfy tax withholding obligations in connection with the vesting of restricted stock issued to the Reporting person under the Amended and Restated Dawson Geophysical Company 2006 Stock and Performance Incentive Plan." Following this transaction, Mays Ray L now owns a total of 100,534 shares.
Impact
This transaction may have implications for executive compensation practices within the oil and gas field exploration services sector. As companies navigate stock management and tax obligations, they may need to consider how such actions affect shareholder perceptions and executive retention strategies. Mays Ray L's actions could influence how other executives within the industry manage their stock holdings and tax liabilities.
What's Next
The filing does not say what happens next.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






